Highlights Topline data for ATH434-201 randomized, double-blind Phase 2 clinical trial on track for expected release by early February 2025ATH434-201 trial in early-stage MSA completed in November ...

Torrent Pharma, which is also the flagship company of the Torrent Group, announced an interim dividend of ₹26 per share for ...

Granules India shares declined beyond 3.5 percent on Friday, January 24, following the announcement of its weak Q3FY25 ...

The largest small finance bank in India, AU Small Finance Bank, said in an exchange filing on Friday that its net profit for ...

Syngene International slumped 6.17% to Rs 795 after the company projected single-digit revenue growth and flat profit after tax (PAT) for the full year, with unchanged EBITDA guidance.

Shares of Cyient Ltd plunged 24% to Rs 1,328.90 after a weak Q3 performance and the resignation of CEO Karthikeyan Natarajan.

The company's Earnings Before Interest, Taxes, Depreciation, Amortization and Restructuring (EBITDAR) stood at ₹6,059 crore.

Indian banks face profitability challenges due to credit costs, NIM contraction, and competition, with 2025 a critical year ...

Syngene International declined 6.17% to Rs 795 after the company projected single-digit revenue growth and flat profit after tax (PAT) for the full year, with unchanged EBITDA guidance.

The airline's revenue from operations rose 13.7 per cent to Rs 22,110.7 crore from Rs 19,452.1 crore in the year-ago period.